Cytogam

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2013
02419942013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
BACKGROUND We have previously shown that the preemptive use of cytomegalovirus (CMV) immunoglobulin (Ig) replacement (CytoGam… (More)
Is this relevant?
2003
2003
BACKGROUND Cytomegalovirus (CMV) infection remains a serious problem after lung transplantation. The purpose of this study was to… (More)
Is this relevant?
2001
2001
Liver and intestinal transplant recipients at the University of Miami receive an intensive regimen of cytomegalovirus (CMV… (More)
Is this relevant?
2001
2001
To explore mechanisms by which antibody might inhibit cytomegalovirus (CMV), we measured the ability of intravenous CMV-IgG… (More)
Is this relevant?
Review
2001
Review
2001
A historical review of the development of cytomegalovirus hyperimmune globulin (CMV-IG, CytoGam) shows its increasing use in… (More)
Is this relevant?
2001
2001
Hypogammaglobulinemia (HGG) in solid organ transplant (SOT) patients confers an increased risk of opportunistic infections and… (More)
Is this relevant?
2000
2000
One of the important parameters for prolonged waiting time for potential renal transplant recipients is the presence of preformed… (More)
Is this relevant?
Review
1999
Review
1999
CytoGam is a hyperimmune globulin created specifically for prophylactic use when a cytomegalovirus seronegative patient receives… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE To assess impact of cytomegalovirus (CMV) donor-recipient serostatus, infection, or disease on development of invasive… (More)
Is this relevant?
1994
1994
The purpose of this study was to analyze different regimens of viral prophylaxis after combined pancreas-kidney transplantation… (More)
Is this relevant?